Denosumab for Type 1 Diabetes

NCT06524960 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DRUG: Denosumab
OTHER: Placebo

Sponsor

City of Hope Medical Center